Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
A phase II study of single agent abraxane as...
Conference

A phase II study of single agent abraxane as second-line therapy in patients with advanced urothelial carcinoma

Authors

Sridhar SS; Canil CM; Eisen A; Tannock IF; Knox JJ; Reaume N; Mukherjee SD; Winquist E; Chung A; Ko YJ

Volume

27

Publisher

AMER SOC CLINICAL ONCOLOGY

Publication Date

May 20, 2009

Name of conference

45th Annual Meeting of the American-Society-of-Clinical-Oncology

Conference place

Orlando, FL

Conference start date

May 29, 2009

Conference end date

June 2, 2009

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

15

ISSN

0732-183X

Labels

Fields of Research (FoR)